Patient care involving genetics is challenging for nongenetics health-care providers. Clinical decision support (CDS) tools are a potential solution because they provide patient-specific risk assessments and/or management recommendations. This systematic review synthesized evidence on whether using CDS tools resulted in appropriate changes in genetics-related patient management made by nongenetics health-care providers.
A comprehensive search in MEDLINE, Embase, and CINAHL yielded 2,239 unique articles. Two independent reviewers screened abstracts and full texts for quantitative, qualitative, and mixed-methods articles on management changes by nongenetics clinicians using a CDS tool as part of patient care. Effect sizes were calculated for quantitative studies and all articles were analyzed together using narrative synthesis. Twenty articles were included.
In 12/16 quantitative studies, CDS tools slightly increased appropriate changes in management, but study design appeared to affect the statistical significance of the effect. The qualitative data in the four remaining studies reaffirmed that CDS tools facilitated management decisions but raised questions about their effect on patient outcomes.
Our review assessed clinical utility of CDS tools, finding that they slightly increase appropriate management changes by nongenetics providers. Future studies on CDS tools should explicitly evaluate decision making and patient outcomes.
Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Data relevant to this systematic review is available upon request.
Mikat-Stevens, N. A., Larson, I. A. & Tarini, B. A. Primary-care providers’ perceived barriers to integration of genetics services: a systematic review of the literature. Genet. Med. 17, 169–176, https://doi.org/10.1038/gim.2014.101 (2015).
Carroll, J.C., Allanson, J. & Morrison, S. et al. Informing integration of genomic medicine into primary care: an assessment of current practice, attitudes, and desired resources. Front. Genet. 10, 1189, https://doi.org/10.3389/fgene.2019.01189 (2019).
Krier, J. B., Kalia, S. S. & Green, R. C. Genomic sequencing in clinical practice: applications, challenges, and opportunities. Dialogues Clin. Neurosci. 18, 299–312 (2016).
Berberich, A. J., Ho, R. & Hegele, R. A. Whole genome sequencing in the clinic: empowerment or too much information? CMAJ. 190, E124–E125, https://doi.org/10.1503/cmaj.180076 (2018).
Overby, C. L., Kohane, I. & Kannry, J. L. et al. Opportunities for genomic clinical decision support interventions. Genet. Med. 15, 817–823, https://doi.org/10.1038/gim.2013.128 (2013).
Sim, I. et al. Clinical decision support systems for the practice of evidence-based medicine. J. Am. Med. Inform. Assoc. 8, 527–534, http://www.ncbi.nlm.nih.gov/pubmed/11687560 (2001).
Grosse, S. D. & Khoury, M. J. What is the clinical utility of genetic testing? Genet. Med. 8, 448–450, https://doi.org/10.1097/01.gim.0000227935.26763.c6 (2006).
Welch, B. M. & Kawamoto, K. Clinical decision support for genetically guided personalized medicine: a systematic review. J. Am. Med. Inform. Assoc. 20, 388–400, https://doi.org/10.1136/amiajnl-2012-000892 (2013).
Bombard, Y., Bach, P. B. & Offit, K. Translating genomics in cancer care. J. Natl. Compr. Canc. Netw. 11, 1343–1353, http://www.ncbi.nlm.nih.gov/pubmed/24225968 (2013).
Lizarondo. L. et al. Mixed methods systematic reviews. In: Aromataris E, Munn Z, eds. Joanna Briggs Institute Reviewer’s Manual. The Joanna Briggs Institute; Adelaide, Australia; 2019. Accessed May 19, 2020. https://reviewersmanual.joannabriggs.org/.
Hong, Q. N., Pluye, P., Bujold, M. & Wassef, M. Convergent and sequential synthesis designs: implications for conducting and reporting systematic reviews of qualitative and quantitative evidence. Syst. Rev. 6, 61, https://doi.org/10.1186/s13643-017-0454-2 (2017).
Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 339, 332–336, https://doi.org/10.1136/bmj.b2535 (2009).
Ouzzani, M., Hammady, H., Fedorowicz, Z. & Elmagarmid, A. Rayyan—a web and mobile app for systematic reviews. Syst. Rev. 5, 210, https://doi.org/10.1186/s13643-016-0384-4 (2016).
Vassy, J. L., Bates, D. W. & Murray, M. F. Appropriateness: a key to enabling the use of genomics in clinical practice? Am. J. Med. 129, 551–553, https://doi.org/10.1016/j.amjmed.2016.02.010 (2016).
Mirzazadeh, A., Malekinejad, M. & Kahn, J. G. Relative risk reduction is useful metric to standardize effect size for public heath interventions for translational research. J. Clin. Epidemiol. 68, 317–323, https://doi.org/10.1016/j.jclinepi.2014.11.013 (2015).
Azzopardi, D. Group comparison calculator. http://www.neoweb.org.uk/Additions/compare.htm (2019).
Andrade, C. Understanding relative risk, odds ratio and related terms: as simple as it can get. J. Clin. Psychiatry. 76, e857–e861 (2015).
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR When does it make sense to perform a meta-analysis? In: Introduction to Meta-Analysis. John Wiley and Sons; Chichester, West Sussex, United Kingdom; 2009:357-64. https://doi.org/10.1002/9780470743386.
Lockwood, C. et al. Chapter 2: Systematic reviews of qualitative evidence. In: Aromataris E, Munn Z, eds. Joanna Brigg’s Institute Reviewer’s Manual. The Joanna Briggs Institute; Adelaide, Australia; 2017. Accessed May 21, 2020. https://wiki.joannabriggs.org/display/MANUAL/Chapter+2%3A+Systematic+reviews+of+qualitative+evidence.
Tufanaru C, Munn Z, Aromataris E, Campbell JHL Chapter 3: Systematic reviews of effectiveness. In: Aromataris E, Munn Z, eds. Joanna Briggs Institute Reviewer’s Manual. The Joanna Briggs Institute; Adelaide, Australia; 2017. Accessed April 25, 2019. https://reviewersmanual.joannabriggs.org/.
Balshem, H. et al. Finding Grey Literature Evidence and Assessing for Outcome and Analysis Reporting Biases When Comparing Medical Interventions: AHRQ and the Effective Health Care Program Methods Guide for Comparative Effectiveness Reviews.; Rockville, Maryland, United States; 2013. Accessed October 14, 2020. www.effectivehealthcare.ahrq.gov/reports/final.cfm.
Blasco-Fontecilla, H. Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders. J. Neural Transm. (Vienna). 126, 101–107, https://doi.org/10.1007/s00702-018-1882-4 (2019).
Borden, B. A. et al. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study. Pharmacogenet. Genomics 29, 31–38, https://doi.org/10.1097/FPC.0000000000000362 (2019).
Edelman, E. A. et al. Implementation of an electronic genomic and family health history tool in primary prenatal care. Am. J. Med. Genet. C. 166, 34–44 (2014).
Michalopoulos, S. N. et al. Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study. Curr. Med. Res. Opin. 30, 1547–1556, https://doi.org/10.1185/03007995.2014.919908 (2014).
Petzel, S. V., Vogel, R. I., McNiel, J., Leininger, A., Argenta, P. A. & Geller, M. A. Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system. Int. J. Gynecol. Cancer 24, 1003–1009, https://doi.org/10.1097/IGC.0000000000000148 (2014).
Badani, K. et al. Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: A report from the DECIDE study group. Oncotarget. 4, 600–609, https://doi.org/10.18632/oncotarget.918 (2013).
Baer, H. J. et al. Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care. J. Gen. Intern. Med. 28, 817–824, https://doi.org/10.1007/s11606-013-2338-z (2013).
Hall-Flavin, D. K. et al. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting. Pharmacogenet. Genomics 23, 535–548, https://doi.org/10.1097/FPC.0b013e3283649b9a (2013).
Scheuner, M. T. et al. A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians. Genet. Med. 16, 60–69, https://doi.org/10.1038/gim.2013.75 (2014).
Emery, J. et al. The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br. J. Cancer 97, 486–493, https://doi.org/10.1038/sj.bjc.6603897 (2007).
Wilson, B. J. et al. Cluster randomized trial of a multifaceted primary care decision-support intervention for inherited breast cancer risk. Fam. Pract. 23, 537–544, https://doi.org/10.1093/fampra/cml026 (2006).
Tural, C. et al. Clinical utility of HIV-1 genotyping and expert advice: the Havana trial. AIDS. 16, 209–218, https://doi.org/10.1097/00002030-200201250-00010 (2002).
Kim, K., Magness, J. W., Nelson, R., Baron, V. & Brixner, D. I. Clinical utility of pharmacogenetic testing and a clinical decision support tool to enhance the identification of drug therapy problems through medication therapy management in polypharmacy patients. J. Manag. Care Spec. Pharm. 24, 1251 (2018).
O’Donnell, P. H. K. et al. Pharmacogenomics-based point-of-care clinical decision support significantly alters drug prescribing. Clin. Pharmacol. Ther. 102, 859–869, https://doi.org/10.1002/cpt.709 (2017).
Brixner, D. A. et al. The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy. J. Med. Econ. 19, 213–228, https://doi.org/10.3111/13696998.2015.1110160 (2016).
Klinkenberg-Ramirez, S. et al. Evaluation: a qualitative pilot study of novel information technology infrastructure to communicate genetic variant updates. Appl. Clin. Inform. 7, 461–476, https://doi.org/10.4338/ACI-2015-11-RA-0162 (2016).
Unertl, K. M., Field, J. R., Price, L. & Peterson, J. F. Clinician perspectives on using pharmacogenomics in clinical practice. Per. Med. 12, 339–347, https://doi.org/10.2217/PME.15.10 (2015).
Doerr, M., Edelman, E., Gabitzsch, E., Eng, C. & Teng, K. Formative evaluation of clinician experience with integrating family history-based clinical decision support into clinical practice. J. Pers. Med. 4, 115–136, https://doi.org/10.3390/jpm4020115 (2014).
Orlando, L. A. et al. Clinical utility of a Web-enabled risk-assessment and clinical decision support program. Genet. Med. 18, 1020–1028, https://doi.org/10.1038/gim.2015.210 (2016).
Singh, A. B. Improved antidepressant remission in major depression via a pharmacokinetic pathway polygene pharmacogenetic report. Clin. Psychopharmacol. Neurosci. 13, 150–156, https://doi.org/10.9758/cpn.2015.13.2.150 (2015).
Gottesman, O. et al. The CLIPMERGE PGx program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics. Clin. Pharmacol. Ther. 94, 214–217, https://doi.org/10.1038/clpt.2013.72 (2013).
Kawamoto, K., Houlihan, C. A., Balas, E. A. & Lobach, D. F. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 330, 765, https://doi.org/10.1136/bmj.38398.500764.8F (2005).
Sutton, R. T., Pincock, D., Baumgart, D. C., Sadowski, D. C., Fedorak, R. N. & Kroeker, K. I. An overview of clinical decision support systems: benefits, risks, and strategies for success. npj Digit. Med. 3, 1–10, https://doi.org/10.1038/s41746-020-0221-y (2020).
Williams, M. S. et al. Genomic information for clinicians in the electronic Health record: lessons learned from the Clinical Genome Resource Project and the Electronic Medical Records and Genomics Network. Front. Genet. 10, 1059, https://doi.org/10.3389/fgene.2019.01059 (2019).
This project is partially funded by an Early Career Award from the Ontario Ministry of Research and Innovation (ER17-13-045). A.S. was supported by an Ontario Graduate Scholarship from the University of Toronto. Y.B. was supported by a New Investigator Award from the Canadian Institutes of Health Research (CIHR). We thank Andrea Tricco, Lusine Abrahamyan, and Petros Pechlivanoglou for their advice and feedback over the course of this study.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sebastian, A., Carroll, J.C., Oldfield, L.E. et al. Effect of genetics clinical decision support tools on health-care providers’ decision making: a mixed-methods systematic review. Genet Med (2021). https://doi.org/10.1038/s41436-020-01045-1